Preventive effect of estrogen on postmenopausal bone loss.

Area of Science:

• Bone biology
• Endocrinology
• Gerontology

Background:

• Postmenopausal osteoporosis is a significant health concern.
• Bone mineral density (BMD) declines after menopause.
• Estrogen's role in bone metabolism is well-established.

Purpose of the Study:

• To investigate the long-term effects of estrogen administration on bone mineral content in postmenopausal women.
• To compare bone loss rates in women with natural versus artificial menopause, with and without estrogen treatment.

Main Methods:

• Follow-up study of 82 postmenopausal women 4-10 years after initial assessment.
• Patients categorized into four groups based on menopause type (natural/artificial) and estrogen status (treated/untreated).
• Bone mineral content and combined cortical thickness of the radius were measured.

Main Results:

• Untreated women showed significant decreases in bone mineral mass and cortical thickness.
• Annual bone loss rates in untreated women were -9.1 mg/sq cm (artificial menopause) and -6.9 mg/sq cm (natural menopause).
• Estrogen-treated subjects had a mean annual change of +3.25 mg/sq cm, significantly different from untreated subjects (-7.99 mg/sq cm).

Conclusions:

• Estrogen treatment appears to prevent bone loss in postmenopausal women.
• Postmenopausal osteoporosis may be preventable with timely estrogen administration.
• The rate of bone loss was not correlated with age in the studied groups.